Diabetes & Obesity Research Review Issue 131
posted by Research Admin 1 on 12 November 2019
Welcome to Issue 131 of Diabetes and Obesity Research Review.
Evidence continues to support the cardiovascular benefits of GLP-1 receptor agonists among patients with type 2 diabetes – including a systematic review and meta-analysis featured in this issue.
Other highlights include:
• Quality of dietary fat and genetic risk of type 2 diabetes.
• An anti-CD3 antibody for prevention of type 1 diabetes among high-risk individuals.
• Pregnancy and perinatal outcomes following bariatric surgery.
This Research Review has 1 attachment
- NZ-Diabetes-and-Obesity-Research-Review-Issue-131_1.pdf.aspx_ext=.pdf (PDF, 1,003.1 KB)